Skip to main content
Log in

Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology

  • Special Article
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arth Rheum 25:1271–1277, 1982

    Google Scholar 

  2. Du Cange D:Glossarium medie et infirme latinitatis; Tomus Quartus, Paris, Instituti Regh Francl, Parisiis Excudebant Firmin diot frates, 1845, pp 162–163

    Google Scholar 

  3. Hebra F, Elfinger A:Atlas der hautkrankheiten, Text von Ferdinand Hebra. Wien Braumuller, Bilder von Anton Elfinger, 1856, plate 6–plate 8

    Google Scholar 

  4. Kaposi M: Nueu Beitrage zur Kenntniss des Lupus Erythematosus. Arch Dermatol Syphil 4:36–78, 1891

    Google Scholar 

  5. Merrill M, Schulman LE: Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chron Dis 1:12–32, 1955

    Google Scholar 

  6. Fessel WJ: Systemic lupus erythematosus in the community: Incidence, prevalence, outcome, first symptoms; The high prevalence in black women. Arch Intern Med 134:1027–1035, 1974

    Google Scholar 

  7. Robbins WC, Holman HR, Deicher H, Kunkel HG: Complement fixation with cells nuclei and DNA in lupus erythematosus. Proc Soc Exp Biol Med 96:575–579, 1957

    Google Scholar 

  8. Tan EM, Schur PH, Corr RI, Kunkel HG: Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 45:1732–1740, 1966

    Google Scholar 

  9. Koffler D, Schur PH, Kunkel HG: Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med 12:607–623, 1967

    Google Scholar 

  10. Koffler D, Kunkel HG: Mechanisms of renal injury in systemic lupus erythematosus. Am J Med 45:165–169, 1968

    Google Scholar 

  11. Koffler D, Agnello V, Kunkel HG: Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus. Am J Pathol 74:109–122, 1974

    Google Scholar 

  12. Lloyd W, Schur PH: Immune complexes, complement and anti-DNA in exacerabations of systemic lupus erythematosus (SLE). Medicine 60:208–217, 1981

    Google Scholar 

  13. Hahn BH, Kalunian KC, Fronek Z, Panosian-Sahakian N, Louie JS, McDevitt HO, Ebling FM: Idiotypic characteristics of immunoglobulins associated with human systemic lupus erythematosus. Association of high serum levels of IdGN2 with nephritis but not with HLA class II genes predisposing to nephritis. Arth Rheum 33:978–984, 1990

    Google Scholar 

  14. Pisetsky DS, Grudier JP, Gilkeson GS: A role for immunogenic DNA in the pathogenesis of systemic lupus erythematosus. Arth Rheum 33:153–159, 1990

    Google Scholar 

  15. van Es JH, Meyling FHJG, van de Akker WRM, Aanstoot H, Derksen RHWM, Logtenberg T: Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus. J Exp Med 173:461–470, 1991

    Google Scholar 

  16. Maddison PJ, Reichlin M: Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus. Arth Rheum 22:858–863, 1979

    Google Scholar 

  17. Penner E, Reichlin M: Primary biliary cirrhosis associated with Sjogren's syndrome: Evidence for circulating and tissue-deposited Ro/anti-Ro immune complexes. Arth Rheum 25:1250–1253, 1982

    Google Scholar 

  18. Lee LA, Gaither KK, Coulter SN, Norris DA, Harley JB: Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice. J Clin Invest 83:1556–1562, 1989

    Google Scholar 

  19. Jones BR: Lacrimal and salivary pricipitating antibodies in Sjogren's syndrome. Lancet 2:773–776, 1958

    Google Scholar 

  20. Anderson JR, Gray KG, Beck JS,et al.: Precipitating autoantibodies in Sjogren's disease. Lancet 2:456–460, 1961

    Google Scholar 

  21. Anderson JR, Gray KG, Beck JS,et al.: Precipitating autoantibodies in the connective tissue diseases. Ann Rheum Dis 21:360–369, 1962

    Google Scholar 

  22. MacSween RNM, Goudie RB, Anderson JR, Armstrong E, Murry MA, Mason DK, Jasani MK, Boyle JA, Buchanan WW, Williamson J: Occurence of antibody to salivary duct epithelium in Sjogren's disease, rheumatoid arthritis and other arthritides: A clinical and laboratory study. Ann Rheum Dis 26:402–411, 1967

    Google Scholar 

  23. Harley JB, Sestak AS, Willis LG, Fu SM, Hansen JA, Reichlin M: A model for disease heterogeniety in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies and lymphpopenia or renal disease. Arth Rheum 32:826–836, 1989

    Google Scholar 

  24. Munves EF, Schur PH: Antibodies to Sm and RNP: Prognosticators of disease involvement. Arth Rheum 26:848–853, 1983

    Google Scholar 

  25. Reichlin M, Rader MD, Harley JB: Autoimmune response to the Ro/SSA particle is directed to the human antigen. Clin Exp Immunol 76:373–377, 1989

    Google Scholar 

  26. Reichlin M, Mattioli M: Correlation of a precipitin reaction to an RNA protein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus. N Engl J Med 286:908–911, 1972

    Google Scholar 

  27. Fisher DE, Conner GE, Reeves WH, Wisniewolski R, Blobel G: Small nuclear ribonucleoprotein particle assembly in vivo: Demonstration of a 6S RNA-free core precursor and posttranslational modification. Cell 42:751–758, 1985

    Google Scholar 

  28. Fisher DE, Reeves WH, Conner GE, Blobel G, Kunkel HG: Pulse labeling of small nuclear ribonucleoproteins in vivo reveals distinct patterns of antigen recognition by human autoimmune antibodies. Proc Natl Acad Sci USA 81:3185–3189, 1984

    Google Scholar 

  29. Hinterberger M, Pettersson I, Steitz JA: Isolation of small nuclear ribonucleoproteins containing U1, U2, U4, U5, and U6 RNAs. J Biol Chem 258:2604–2613, 1983

    Google Scholar 

  30. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR: Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148–159, 1972

    Google Scholar 

  31. Reichlin M, van Venrooij WJ: Autoantibodies to the URNP particles: Relationship to clinical diagnosis and nephritis. Clin Exp Immunol 83:286–290, 1991

    Google Scholar 

  32. Nimelstein SH, Brody S, McShane D, Holman HR: Mixed connective tissue disease: A subsequent evaluation of the original 25 patients. Medicine (Baltimore) 59:239–248, 1980

    Google Scholar 

  33. Black CM, Maddison PJ, Welsh KI, Woodrow JC, Pereira RS: HLA and Ig allotype in mixed connective tissue disease. Arth Rheum 31:131–134, 1988

    Google Scholar 

  34. Stephano JE: Purified lupus antigen La recognizes an oligo uridylate stretch common to the 3′ termini of RNA polymerase III transcripts. Cell 36:145–154, 1984

    Google Scholar 

  35. Lerner MR, Andrews NC, Miller G, Steitz JA: Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 78:805–809, 1981

    Google Scholar 

  36. Kurilla MG, Keene JD: The leader RNA of vesicular stomatitis virus is bound by a cellular protein reactive with anti-La lupus antibodies. Cell 34:837–845, 1983

    Google Scholar 

  37. Rosa MA, Gottleib E, Lerner MR, Steitz JA: Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleis acids VAI and VAII. Mol Cell Biol 1:785–796, 1981

    Google Scholar 

  38. Deutscher S, Harley JB, Keene JD: Molecular analysis of the 60 kD human Ro ribonucleoprotein. Proc Natl Acad Sci 85:9479–9483, 1988

    Google Scholar 

  39. O'Brien CA, Harley JB: A subset of Y RNAs are associated with erythrocyte Ro ribonucleoproteins. EMBO J 9:3683–3689, 1990

    Google Scholar 

  40. Wolin SL, Steitz JA: The Ro small cytoplasmic ribonucleoproteins: Identification of the antigenic protein and its binding site on the Ro RNAs. Proc Natl Acad Sci USA 81:1996–2000, 1984

    Google Scholar 

  41. McCauliffe DP, Zappi E, Lieu TS, Michalak M, Sontheimer RD, Capra JD: A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia “memory molecule.” J Clin Invest 86:332–335, 1990

    Google Scholar 

  42. Ben-Chetrit E, Chan EKL, Sullivan KF, Tan EM: A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med 167:1560–1571, 1988

    Google Scholar 

  43. Rader MD, O'Brien CA, Liu YS, Harley JB, Reichlin M: Heterogeneity of the Ro/SSA antigen. Different molecular forms in lymphocytes and red blood cells. J Clin Invest 83:1293–1298, 1989

    Google Scholar 

  44. Itoh K, Itoh Y, Frank MB: Protein heterogeniety of the human ribonucleoprotein: The 52 and 60 kD Ro/SSA autoantigens are encoded by separate genes. J Clin Invest 87:177–186, 1991

    Google Scholar 

  45. Tiwari TL, Terasaki PI: HLA and Disease Associations. New York, Springer-Verlag, 1985, pp 363–378

    Google Scholar 

  46. Reveille JD, Arnett FC, Wilson RW, Bias WB, McLean RH: Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus. Immunogenetics 21:299–311, 1985

    Google Scholar 

  47. Howard PF, Hochberg MC, Bias WB, Arnett FC, McLean RH: Relationship between C4A null genes, HLA-D region antigens and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. Am J Med 81:187–193, 1986

    Google Scholar 

  48. Kemp ME, Atkinson JP, Skanes VM, Levine RP, Chaplin DD: Deletion of C4A genes in patients with systemic lupus erythematosus. Arth Rheum 30:1015–1022, 1987

    Google Scholar 

  49. Provost TT, Arnett FC, Reichlin M: Homozygous C2 deficiency, lupus erythematosus and anti-Ro (SSA) antibodies. Arth Rheum 26:1279–1282, 1983

    Google Scholar 

  50. Agnello V: Complement deficiency and systemic lupus erythematosus.In Systemic Lupus Erythematosus, RG Lahita (ed). New York, John Wiley and Sons, 1987, pp 565–592

    Google Scholar 

  51. Kawai T, Katoh K, Narita M, Tani K, Okubo T: Deficiency of the 9th component of complement (C9) in a patient with systemic lupus erythematosus. J Rheumatol 16:542–543, 1989

    Google Scholar 

  52. Stern R, Fishman J, Brushman H, Kunkel HG: Systemic lupus erythematosus associated with Kleinfelter's syndrome. Arth Rheum 20:18–22, 1977

    Google Scholar 

  53. Lahita RG: Sex and age in systemic lupus erythematosus.In Systemic Lupus Erythematosus, RG Lahita (ed). New York, John Wiley & Sons, 1987, pp 523–539

    Google Scholar 

  54. Lavalle C, Loyo E, Paniagua R, Bermudez JA, Herrera J, Graef A, Gonzalez-Barcena D, Fraga A: Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 14:268–272, 1987

    Google Scholar 

  55. Folomeev M, Prokaeva T, Nassonova V, Nassonov E, Masenko E, Ovtraht N: Prolactin levels in men with SLE and RA. J Rheumatol 17:1569–1570, 1990

    Google Scholar 

  56. Fessel WJ: Epidemiology of systemic lupus erythematosus.In Systemic Lupus Erythematosus: Rheumatic Clinics of North America, JH Klippel (ed). Philadelphia, W. B. Saunders, 1988, pp 15–23

    Google Scholar 

  57. Whittingham S, Mathews JD, Schanfield MS, Tait BD, Mackay IR: HLA and Gm genes in systemic lupus erythematosus. Tissue Antigens 21:50–57, 1983

    Google Scholar 

  58. Fedrick JA, Pandey JP, Chen Z, Fudenberg HH, Ainsworth SK, Dobson RL: Gm allotypes in blacks with systemic lupus erythematosus. Hum Immunol 8:177–181, 1983

    Google Scholar 

  59. Stenszky V, Kozma L, Szegedi G, Farid NR: Interplay of immunoglobulin G heavy chain markers (Gm) and HLA in predisposing to systemic lupus erythematosus. J Immunogenet 13:11–17, 1986

    Google Scholar 

  60. Schur PH, Pandey JP, Fedrick JA: Gm allotypes in white patients with systemic lupus erythematosus. Arth Rheum 28:828–830, 1985

    Google Scholar 

  61. Hoffman RW, Sharp GC, Irvin WS, Anderson SK, Hewett JE, Pandey JP: Association of immunoglobulin Km and Gm allotypes with specific antinuclear antibodies and disease susceptibility among connective tissue disease patients. Arth Rheum 34:453–458, 1991

    Google Scholar 

  62. Harley JB, Alexander EL, Bias WB, Fox OF, Provost TT, Reichlin M, Yamagata H, Arnett FC: Anti-Ro/SSA and anti-La/SSB in Sjogren's syndrome. Arth Rheum 29:196–206, 1986

    Google Scholar 

  63. Whittingham S, Mackay IR, Tait BD: Autoantibodies to small nuclear ribonucleoproteins. A strong association between anti-SS-B(La), HLA-B8 and Sjogren's syndrome. Aust NZ J Med 23:565–570, 1983

    Google Scholar 

  64. Ahearn JM, Provost TT, Dorsch CA, Stevens MB, Bias WB, Arnett FC: Interrelationships of HLA-DR, MB and MT phenotypes, autoantibody expression and clinical features in systemic lupus erythematosus. Arth Rheum 25:1031–1040, 1982

    Google Scholar 

  65. Alvarellos A, Ahearn JM, Provost TT, Dorsch CA, Stevens MB, Bias WB, Arnett FC: Relationships of HLA-DR and MT antigens to autoantibody expression in systemic lupus erythematosus. Arth Rheum 26:1533–1535, 1983

    Google Scholar 

  66. Harley JB, Reichlin M, Arnett FC, Alexander EL, Bias WB, Provost TT: Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren's syndrome. Science 232:1145–1147, 1986

    Google Scholar 

  67. Hamilton RG, Harley JB, Bias WB, Roebber M, Reichlin M, Hochberg MC: Two Ro(SS-A) autoantibody responses in systemic lupus erythematosus correlate with different HLA-DR antigens but show trans-allelic interaction at HLA-DR and DQ. Arth Rheum 31:227–237, 1988

    Google Scholar 

  68. Reveille JD, MacLeod MJ, Whittington K, Arnett FC: Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses. J Immunol 146:3871–3876, 1991

    Google Scholar 

  69. Frank MB, McArthur R, Harley JB, Fujisaku A: Anti-Ro (SSA) autoantibodies are associated with T cell receptor beta genes in systemic lupus erythematosus patients. J Clin Invest 85:33–39, 1990

    Google Scholar 

  70. Hochstenbach F, Brenner MB: Newly identified gamma delta and beta delta T-cell receptors. J Clin Immunol 10:1–18, 1990

    Google Scholar 

  71. Ballou SP, Kushner I: Lupus patients who lack detectable anti-DNA: Clinical features and survival. Arth Rheum 25:1126–1129, 1982

    Google Scholar 

  72. Appel AE, Sablay LB, Golden RA, Barland P, Grayzel AI, Bank N: The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis. A two year prospective study. Am J Med 64:274–283, 1978

    Google Scholar 

  73. Lightfoot RW Jr, Hughes GRV: Significance of persisting serologic abnormalities in SLE. Arth Rheum 19:837–843, 1976

    Google Scholar 

  74. Sontheimer RD, Gilliam JN: DNA antibody class, subclass and complement fixation in SLE with and without nephritis. Clin Immunol Immunopathol 10:459–467, 1978

    Google Scholar 

  75. Johnson RT, Richardson EP: The neurologic manifestations of systemic lupus erythematosus: A clinical-pathological study of 24 cases and review of the literature. Medicine 47:337–369, 1968

    Google Scholar 

  76. Ellis SG, Verity MA: Central nervous system involvement in systemic lupus erythematosus a review of neuropathologic findings in 57 cases. Semin Arth Rheum 8:212–221, 1979

    Google Scholar 

  77. Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N, Elkon KB: Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 317:265–271, 1987

    Google Scholar 

  78. Schneebaum AB, Singleton JD, West SG, Blodgett JK, Allen LG, Cherons JC, Kotzin BL: Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 90:54–62, 1991

    Google Scholar 

  79. Harris EN, Gharavi AE, Asherson RA, Boey ML, Hughes GR: Cerebral infarction in systemic lupus: Association with anticardiolipin antibodies. Clin Exp Rheumatol 2:47–51, 1984

    Google Scholar 

  80. Derksen RHWM, Bouma BN, Kater L: The association between lupus anticoagulant and cerebral infarction in systemic lupus erythematosus. Scand J Rheumatol 15:179–184, 1986

    Google Scholar 

  81. Meyer O, Piette J-C, Bourgeois P: Antiphospholipid antibodies: A disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE): Comparison with a group of 91 patients with antinuclear antibody positive SLE. J Rheumatol 14:502–506, 1987

    Google Scholar 

  82. Bluestein HG: Neurocytotoxic antibodies is serum of patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 75:3965–3969, 1978

    Google Scholar 

  83. Bresnihan B, Oliver M, Williams B, Hughes GRV: An antineuronal antibody cross-reacting with erythocytes and lymphocytes in systemic lupus erythematosus. Arth Rheum 22:313–320, 1979

    Google Scholar 

  84. Wilson HA, Winfield JB, Lahita RG, Koffler D: Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus. Arth Rheum 22:458–462, 1979

    Google Scholar 

  85. How A, Dent PB, Liao S-K, Denburg JA: Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus. Arth Rheum 28:789–795, 1985

    Google Scholar 

  86. Bluestein HG, Williams GW, Steinberg AD: Cerebrospinal fluid antibodies to neuronal cells: Association with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 70:240–246, 1981

    Google Scholar 

  87. Fauci AS, Moutsopoulos HM: Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjogren's syndrome. Arth Rheum 24:577–584, 1981

    Google Scholar 

  88. Klinman DM, Steinberg AD: Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 165:1755–1760, 1987

    Google Scholar 

  89. Eisenberg RA, Dyer K, Craven SY, Fuller CR, Yount WJ: Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm. J Clin Invest 75:1270–1277, 1985

    Google Scholar 

  90. Gharavi AE, Chu JL, Elkon KB: Autoantibodies to intracellular proteins in human systemic lupus erythematosus are not due to random polyclonal B cell activation. Arth Rheum 31:1337–1345, 1988

    Google Scholar 

  91. Plotz PH: Autoantibodies are anti-idiotype antibodies to antiviral antibodies. Lancet 2:824–826, 1987

    Google Scholar 

  92. Blomgren SE, Condemi JJ, Bignall MC: Antinuclear antibody induced by procainamide: A prospective study. N Engl J Med 281:64, 1969

    Google Scholar 

  93. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M: Evidence for impaired T-cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arth Rheum 33:1665–1673, 1990

    Google Scholar 

  94. Malinow MR, Bardana EJ, Pirofsky B, Craig S, McLaughlin P: Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: Role of a nonprotein amino acid. Science 216:415–417, 1982

    Google Scholar 

  95. Fernandes G, Venkatraman J, Khare A, Horbach GJ, Friedrichs W: Modulation of gene expression in autoimmune disease and aging by food restriction and dietary lipids. Proc Soc Exp Biol Med 193:16–22, 1990

    Google Scholar 

  96. Alcocer-Varela J, Iglesias A, Llorente L, Alarcon-Segovia D: Effects of 1-canavaninie on T cells may explain the induction of systemic lupus erythematosus by alfalfa. Arth Rheum 28:52–57, 1985

    Google Scholar 

  97. Morimoto I, Shiozawa S, Tanaka Y, Fujita T: L-canavanine acts on suppressor-inducer T cells to regulate antibody synthesis: lymphocytes of systemic lupus erythematosus patients are specifically unresponsive to L-canavanine. Clin Immunol Immunopathol 55:97–108, 1990

    Google Scholar 

  98. Roberts JL, Hayashi JA: Exacerbation of SLE associated with alfalfa ingestion. N Engl J Med 308:1361, 1983

    Google Scholar 

  99. Feikje M, van Rappard VDV, Rolink AG, Gleichmann E: Diseases caused by reactions of T lymphocytes towards incompatible structures of the major histocompatibility complex. J Exp Med 155:1555–1560, 1982

    Google Scholar 

  100. Winchester RJ, Lahita RG: Genetic susceptibility to systemic lupus erythematosus.In Systemic Lupus Erythematosus, RG Lahita (ed). New York, John Wiley & Sons, 1987, pp 81–118

    Google Scholar 

  101. Alocer-Varela G, Alarcon-Segovia D: Decreased production of and response to IL-2 by cultured lymphocytes from patients with SLE. J Clin Invest 69:1388–1392, 1982

    Google Scholar 

  102. Huang YP, Perrin LH, Miescher PA, Zubler RH: Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J Immunol 141:827–833, 1988

    Google Scholar 

  103. Mendelovic S, Brocke S, Shoenfeld Y, Ben-Bassat M, Meshorer A, Bakimer R, Mozes E: Induction of an SLE-like disease in mice by a common anti-DNA idiotype. Proc Natl Acad Sci USA 85:2260–2264, 1988

    Google Scholar 

  104. Mozes E, Mendlovic S, Kalush F, Waisman A, Shoenfield Y, Fricke H: Immunoregulation of autoimmune diseases. Isr J Med Sci 26:688–690, 1990

    Google Scholar 

  105. Mendlovic S, Brocke S, Fricke H, Shoenfeld Y, Bakimer R, Mozes E: The genetic regulation of the induction of experimental SLE. Immunology 69:228–236, 1990

    Google Scholar 

  106. Fricke H, Offen D, Mendlovic S, Shoenfeld Y, Bakimer R, Sperling J, Mozes E: Induction of experimental SLE in mice by immunization with a monoclonal anti-La autoantibody. Int Immunol 2:225–230, 1990

    Google Scholar 

  107. Shoenfeld Y, Mozes E: Pathogenic idiotypes of autoantibodies in autoimmunity: lessons from new experimental models of SLE. FASEB J 4:2646–2651, 1990

    Google Scholar 

  108. Mendlovic S, Fricke H, Shoenfeld Y, Mozes E: The role of anti-idiotypic antibodies in the induction of experimental systemic lupus erythematosus in mice. Eur J Immunol 19:729–732, 1989

    Google Scholar 

  109. Srinivasappa J, Saegusa J, Prabhakar BS, Gentry MK, Buchmeier J, Wiktor TJ, Koprowski H, Oldstone MBA, Notkins AL: Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol 57:397–401, 1986

    Google Scholar 

  110. Zinkernagel RM, Cooper S, Chambers J, Lazzarini RA, Hengartner H, Arnheiter H: Virus-induced autoantibody response to a transgenic viral antigen. Nature 345:68–71, 1990

    Google Scholar 

  111. Ohashi PS, Oehen S, Buerki K, Pircher H, Ohashi CT, Odermatt B, Malissen B, Zinkernagel RM, Hengartner H: Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen. Cell 65:305–317, 1991

    Google Scholar 

  112. Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H: Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response. Cell 65:319–331, 1991

    Google Scholar 

  113. Talal N, Garry RF, Schur PH, Alexander SS, Dauphinee MJ, Livas IH, Ballester A, Takei M, Dang H: A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest 85:1866–1871, 1991

    Google Scholar 

  114. Talal N, Dauphin:ee MJ, Dang H, Alexander SS, Hart DJ, Garry RF: Detection of serum antibodies to retroviral proteins in patients with primary Sjogren's syndrome (autoimmune exocrinopathy). Arth Rheum 33:774–781, 1990

    Google Scholar 

  115. Harisdangkul V, Lazo A, Bailer R, Blakeslee J: Detection of HTLV 1 related proviral sequences in cell line established from a patient with SLE. Arth Rheum 34:R23, 1991

    Google Scholar 

  116. Imamura M, Phillips PE, Mellors RC: The occurrence and frequency of type C virus-like particles in placentas from patients with systemic lupus erythematosus and from normal subjects. Am J Pathol 83:383–394, 1976

    Google Scholar 

  117. Oldstone MBA: Molecular mimicry and autoimmune disease. Cell 50:819–820, 1987

    Google Scholar 

  118. Schwimmbeck PL, Yu DTY, Oldstone MBA: Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. J Exp Med 166:173–181, 1987

    Google Scholar 

  119. Schwimmbeck PL, Dryberg T, Drachman DB, Oldstone MBA: Molecular mimicry and myasthenia gravis: an autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J Clin Invest 84:1174–1180, 1989

    Google Scholar 

  120. Kagnoff MF, Austin RK, Hubert JJ, Bernardin JE, Kasarda DD: Possible role for a human adenovirus in the pathogenesis of celiac disease. J Exp Med 160:1544–1557, 1984

    Google Scholar 

  121. van Voorhis WC, Eisen H: A surface antigen of Trypanosoma cruzi that mimics mammalian nervous tissue. J Exp Med 169:641–652, 1989

    Google Scholar 

  122. Kaplan MH, Svec KH: Immunologic relation of Streptococcal and tissue antigens. III. Presence in human sera of Streptococcal antibody cross-reactive with heart tissue. Association with streptococcal infection, rheumatic fever, and glomerulonephritis. J Exp Med 119:651–666, 1964

    Google Scholar 

  123. Kaplan MH, Bolande R, Rakita L, Blair J: Presence of bound immunoglobulins and complement in the myocardium of acute rheumatic fever. N Engl J Med 271:637–645, 1964

    Google Scholar 

  124. Query CC, Keene JD: A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30(gag) antigen. Cell 51:211–220, 1987

    Google Scholar 

  125. Rucheton M, Graafland H, Valles H, Larsen CJ: Human autoimmune serum antibodies against gag gene p30 retoviral protein also react with a U1-snRNP 68K comigrant protein. Biol Cell 60:71–72, 1987

    Google Scholar 

  126. Nassberger L, Sjoholm AG, Sturfelt G: Absence of circulating antineutrophil cytoplasm antibodies (ANCA) in severe vasculitis associated with rheumatoid arthritis. Scand J Rheumatol 19:189–192, 1990

    Google Scholar 

  127. Flescher E, Talal N: Do viruses contribute to the development of Sjogren's syndrome? Am J Med 90:283–285, 1991

    Google Scholar 

  128. Lehner T, Lavery E, Smith R, van der Zee R, Mizushima Y, Shinnick T: Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behcet's syndrome. Infect Immun 59:1434–1441, 1991

    Google Scholar 

  129. Garry RF, Fermin CD, Hart DJ, Alexander SS, Donehower LA, Luo-Zhang H: Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 250:1127–1129, 1990

    Google Scholar 

  130. Guldner HH, Netter HJ, Szostecki C, Jaeger E, Will H: Human anti-p68 autoantibodies recognize a common epitope of U1 RNA containing small nuclear ribonucleoprotein and influenza B virus. J Exp Med 171:819–829, 1990

    Google Scholar 

  131. Habets WJ, Sillekens PTG, Hoet MH, McAllister G, Lerner MR, van Venrooij WJ: Small nuclear RNA-associated proteins are immunologically related as revealed by mapping of autoimmune reactive B-cell epitopes. Proc Natl Acad Sci USA 86:4674–4678, 1989

    Google Scholar 

  132. Barakat S, Briand J-P, Weber J-C, Van Regenmortel MHV, Muller S: Recognition of synthetic peptides of Sm-D autoantigen by lupus sera. Clin Exp Immunol 81:256–262, 1990

    Google Scholar 

  133. Habets WJ, Hoet MH, de Jong BAW, van der Kemp A, van Venrooij WJ: Mapping of B cell epitopes on small nuclear ribonucleoproteins that react with human autoantibodies as well as with experimentally-induced mouse monoclonal antibodies. J Immunol 143:2560–2566, 1989

    Google Scholar 

  134. Habets WJ, Hoet MH, van Venrooij WJ: Epitope patterns of anti-RNP antibodies in rheumatic diseases. Arth Rheum 33:834–841, 1990

    Google Scholar 

  135. Hines JJ, Danho W, Elkon KB: Detection and quantification of human anti-Sm antibodies using synthetic peptide and recombinant SmB antigens. Arth Rheum 34:572–579, 1991

    Google Scholar 

  136. Gyorkey F, Sinkovics JG, Min KW, Gyorkey P: A morphologic study of the occurrence and distribution of structures resembling viral nucleocapsids in collagen disease. Am J Med 53:148–158, 1973

    Google Scholar 

  137. Pincus T, Blacklow NR, Grimley PM, Bellanti JA: Glomerular microtubules of systemic lupus erythematosus. Lancet 2:1058–1061, 1970

    Google Scholar 

  138. Schaff Z, Barry DW, Grimley PM: Cytochemistry of tubuloreticular structures in lymphocytes from patients with systemic lupus erythematosus and in cultured human lymphoid cells. Lab Invest 29:577–586, 1973

    Google Scholar 

  139. Rich SA, Gibbons WE: Human lupus-type inclusions in umbilical cord blood mononuclear cells. Arth Rheum 33:1420–1425, 1990

    Google Scholar 

  140. Scofield RH, Harley JB: Autoantigenicity of Ro/SSA antigen is related to a nucleocapsid protein of vesicular stomatitis virus. Proc Natl Acad Sci USA 88:3343–3347, 1991

    Google Scholar 

  141. Appel JR, Pinilla C, Niman H, Houghton R: Elucidation of discontinuous linear determinants in peptides. J Immunol 144:967–983, 1990

    Google Scholar 

  142. Bhatt NP, Rodrigues FM: Chandipura: A new arbovirus isolated in India from patients with febrile illness. Ind J Med Res 55:1295–1305, 1967

    Google Scholar 

  143. Tesh RB, Peralta PH, Johnson KM: Ecologic studies of vesicular stomatitis virus. 1. Prevalence of infection among animals and humans living in an area of endemic VSV activity. Am J Epidemiol 90:255–261, 1969

    Google Scholar 

  144. Hoffman RW, Rettenmair LJ, Takeda Y, Hewett JH, Pettersson I, Nyman U, Luger AM, Sharp GC: Human autoantibodies against the 70-kd polypeptide of U1 small nuclear RNP are associated with HLA-DR4 among connective tissue patients. Arth Rheum 33:666–673, 1990

    Google Scholar 

  145. Tesh RB, Roshell SJ, Modi GB, Morales AA, Young DG, Corredor A, Ferro de Carrasquilla C, de Rodriguez C, Walters LL, Gaitan MO: Natural infection of humans, animals, and phlebotomine sand flies with the Alagoas serotype of vesicular stomatitis virus in Colombia. Am J Trop Med 36:653–661, 1987

    Google Scholar 

  146. Fields BN, Hawkins K: Human infection with the virus of vesicular stomatitis during an epizootic. N Engl J Med 277:989–994, 1967

    Google Scholar 

  147. Walton TE, Webb PA, Kramer WL, Smith GC, Davis T, Holbrook FR, Moore CG, Schiefer TJ, Jones RH, Janney GC: Epizootic vesicular stomatitis in Colorado, 1982: Epidemiologic and entomologic studies. Am J Trop Med Hyg 36:166–176, 1987

    Google Scholar 

  148. Reif JS, Webb PA, Monath TP, Emerson JK, Poland JD, Kemp GE, Cholas G: Epizootic vesicular stomatitis in Colorado, 1982: Infection in occupational groups. Am J Trop Med Hyg 36:177–182, 1987

    Google Scholar 

  149. Quiroz E, Moreno N, Peralta PH, Tesh RB: A human case of encephalitis associated with vesicular stomatitis virus (Indiana serotype) infection. Am J Trop Med Hyg 39:312–314, 1988

    Google Scholar 

  150. Hughes JV, Johnson TC: Alterations in peptide structure of vesicular stomatitis virus mutant and its central nervous system isolate. J Gen Virol 53:309–319, 1981

    Google Scholar 

  151. Beebe DP, Cooper NR: Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum. J Immunol 126:1562–1568, 1981

    Google Scholar 

  152. Hooks JJ, Moutsopoulos HM, Notkins AL: The role of interferon in immediate hypersensitivity and autoimmune diseases. Ann NY Acad Sci 350:21–32, 1980

    Google Scholar 

  153. Ytterberg SR, Schnitzer TJ: Serum interferon levels in patients with systemic lupus erythematosus. Arth Rheum 25:401–406, 1982

    Google Scholar 

  154. Yee AM, Yip YK, Fischer HD, Buyon JP: Serum activity that confers acid lability to alpha-interferon in systemic lupus erythematosus: Its association with disease activity and its independence from circulating alpha-interferon. Arth Rheum 33:563–568, 1990

    Google Scholar 

  155. Tsokos GC, Boumpas DT, Smith PL, Djeu JY, Balow JE, Rook AH: Deficient gamma-interferon production in patients with systemic lupus erythematosus. Arth Rheum 29:1210–1215, 1986

    Google Scholar 

  156. Ito Y, Montagnier L: Heterogenity of the sensitivity of vesicular stomatitis virus to interferons. Infect Immun 18:23–27, 1977

    Google Scholar 

  157. Bishop D, Repik P, Obijeski J, Moore N, Wagner R: Restitution of infectivity to spikeless vesicular stomatitis virus by solubilized viral components. J Virol 16:75–84, 1975

    Google Scholar 

  158. Gaccione C, Marcus PI: Interferon induction by viruses. XVIII. Vesicular stomatitis virus-New Jersey: A single infectious particle can both induce and suppress interferon production. J Interferon Res 9:603–614, 1989

    Google Scholar 

  159. Marcus PI, Sekellick MJ: Interferon induction by viruses. XIII. Detection and assay of interferon induction-suppressing particles. Virology 142:411–415, 1985

    Google Scholar 

  160. Marcus PI: Interferon induction by viruses. XV. Biological characteristics of interferon induction-suppressing particles of vesicular stomatitis virus. J Interferon Res 7:269–284, 1987

    Google Scholar 

  161. Marcus PI: Interferon induction by viruses. IX. Antagonistic activities of virus particles modulate interferon production. J Interferon Res 2:511–518, 1982

    Google Scholar 

  162. Di Francesco P, Coccia EM, Gessani S, Romeo G, Borghi P, Locardi C, Belardelli F: Studies on the mechanism of the interferon-mediated antiviral state to vesicular stomatitis virus in resting mouse peritoneal macrophages. J Gen Virol 70:1899–1905, 1989

    Google Scholar 

  163. Younger JS, Preble OT, Jones EV: Persistent infection of L cells with vesicular stomatitis virus: Evolution of virus populations. J Virol 28:6–13, 1978

    Google Scholar 

  164. Holland JJ, Villarreal LP, Welsh RM, Oldstone MBA, Kohne D, Lazzarini R, Scolnick E: Long-term persistent vesicular stomatitis virus and rabies virus infection of cells in vitro. J Gen Virol 33:193–211, 1976

    Google Scholar 

  165. Smith JS, Fishbein DB, Rupprecht CE, Clark K: Unexplained rabies in three immigrants in the United States. A virologic investigation. N Engl J Med 324:207–211, 1991

    Google Scholar 

  166. Fresco LD, Kurilla MG, Keene JD: Rapid inhibition of processing and assembly of small nuclear ribonucleoproteins after infection with vesicular stomatitis virus. Mol Cell Biol 7:1148–1155, 1987

    Google Scholar 

  167. Crone DE, Keene JD: Viral transcription is necessary and sufficient for vesicular stomatitis virus to inhibit maturation of small nuclear ribonucleoproteins. J Virol 63:4172–4180, 1989

    Google Scholar 

  168. Frielle DW, Kim PB, Keene JD: Inhibitory effects of vesicular stomatitis virus on cellular and influenza viral RNA metabolism and protein synthesis. Virology 172:274–284, 1989

    Google Scholar 

  169. Webb DR, Munshi S, Banerjee AK: Replication of vesicular stomatitis virus in murine spleen cells: Enrichment of the virus-replicating lymphocytes and analysis of replication restriction. Infect Immun 32:169–172, 1981

    Google Scholar 

  170. Hom RC, Soman G, Finberg R: Trojan horse lymphocytes: a vesicular stomatitis virus-specific T-cell clone lyses target cells by carrying virus. J Virol 63:4157–4164, 1989

    Google Scholar 

  171. Browning MJ, Huang AS, Reiss CS: Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens. J Immunol 145:985–994, 1990

    Google Scholar 

  172. Jenney EW, Erickson GA, Buisch WW, Stewart WC, Mixson MA: Surveillance for vesicular stomatitis in the United States 1972 through 1979. Amer Assn Veterinary Lab Diagnosticians 83–90, 1980

  173. Bilsel PA, Nichol ST: Polymerase errors accumulating during natural evolution of the glycoprotein gene of vesicular stomatitis virus Indiana serotype isolates. J Virol 64:4873–4883, 1990

    Google Scholar 

  174. Deutscher SL, Harley JB, Keene JD: Molecular analysis of the 60 kD human Ro ribonucleoprotein. Proc Natl Acad Sci USA 85:9479–9483, 1988

    Google Scholar 

  175. Gallione CJ, Greene JR, Iverson LE, Rose JR: Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus N and NS proteins. J Virol 39:529–535, 1981

    Google Scholar 

  176. DePolo NJ, Giachetti C, Holland JJ: Continuing coevolution of virus and defective interfering particles and of viral genome sequences during undiluted passages: virus mutants exhibiting nearly complete resistance to formerly dominant defective interfering particles. J Virol 61:454–464, 1987

    Google Scholar 

  177. Banerjee AK, Rhodes DP, Gill DS: Complete nucleotide sequence of the mRNA coding for the N protein of vesicular stomatitis virus (New Jersey serotype). Virology 137:432–438, 1984

    Google Scholar 

  178. Masters PS, Banerjee AK: Sequences of Chandipura virus N and NS genes: evidence for high mutability of the NS gene within vesiculoviruses. Virology 157:198–306, 1987

    Google Scholar 

  179. Crysler JG, Lee P, Reinders M, Prevec L: The sequence of nucleocapsid protein (N) gene of Piry virus: Possible domains in the N protein of vesiculoviruses. J Gen Virol 71:2191–2194, 1990

    Google Scholar 

  180. Tordo N, Poch O, Keith G: Primary structure of leader RNA and nucleoprotein genes of the rabies genome: Segmented homology with VSV. Nucleic Acids Res 14:1671–2683, 1986

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harley, J.B., Scofield, R.H. Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology. J Clin Immunol 11, 297–316 (1991). https://doi.org/10.1007/BF00918796

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00918796

Key words

Navigation